FLUVOXAMINE MALEATE (fluvoxamine maleate) by Teva is 12. Approved for obsessive compulsive disorder (ocd) (), obsessive compulsive disorder (ocd), defined in the dsm-iv. First approved in 2013.
Drug data last refreshed 20h ago
12.1 Mechanism of Action The mechanism of action of fluvoxamine maleate in obsessive compulsive disorder is presumed to be linked to its specific serotonin reuptake inhibition in brain neurons. Fluvoxamine has been shown to be a potent inhibitor of the serotonin reuptake transporter in preclinical…
Worked on FLUVOXAMINE MALEATE at Teva? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.